期刊文献+

Global prevalence of occult hepatitis C virus: A systematic review and meta-analysis

下载PDF
导出
摘要 BACKGROUND Occult hepatitis C infection(OCI)is characterized by the presence of hepatitis C virus(HCV)RNA in the liver,peripheral blood mononuclear cells(PBMC)and/or ultracentrifuged serum in the absence of detectable HCV-RNA in serum.OCI has been described in several categories of populations including hemodialysis patients,patients with a sustained virological response,immunocompromised individuals,patients with abnormal hepatic function,and apparently healthy subjects.AIM To highlight the global prevalence of OCI.METHODS We performed a systematic and comprehensive literature search in the following 4 electronic databases PubMed,EMBASE,Global Index Medicus,and Web of Science up to 6th May 2021 to retrieve relevant studies published in the field.Included studies were unrestricted population categories with known RNA status in serum,PBMC,liver tissue and/or ultracentrifuged serum.Data were extracted independently by each author and the Hoy et al tool was used to assess the quality of the included studies.We used the random-effect meta-analysis model to estimate the proportions of OCI and their 95%confidence intervals(95%CI).The Cochran's Q-test and the I2 test statistics were used to assess heterogeneity between studies.Funnel plot and Egger test were used to examine publication bias.R software version 4.1.0 was used for all analyses.RESULTS The electronic search resulted in 3950 articles.We obtained 102 prevalence data from 85 included studies.The pooled prevalence of seronegative OCI was estimated to be 9.61%(95%CI:6.84-12.73)with substantial heterogeneity[I^(2)=94.7%(95%CI:93.8%-95.4%),P<0.0001].Seropositive OCI prevalence was estimated to be 13.39%(95%CI:7.85-19.99)with substantial heterogeneity[I^(2)=93.0%(90.8%-94.7%)].Higher seronegative OCI prevalence was found in Southern Europe and Northern Africa,and in patients with abnormal liver function,hematological disorders,and kidney diseases.Higher seropositive OCI prevalence was found in Southern Europe,Northern America,and Northern Africa.CONCLUSION In conclusion,in the present study,it appears that the burden of OCI is high and variable across the different regions and population categories.Further studies on OCI are needed to assess the transmissibility,clinical significance,long-term outcome,and need for treatment.
出处 《World Journal of Methodology》 2022年第3期179-190,共12页 世界方法学杂志
  • 相关文献

参考文献3

二级参考文献137

  • 1Mohamed Darwish Ahmed Abd Alla,Saleh Ahmed Elibiary,George Y.Wu,Mostafa Kamel El-Awady.Occult HCV Infection (OCI) Diagnosis in Cirrhotic and Non-cirrhotic Naive Patients by Intra-PBMC Nested Viral RNA PCR[J].Journal of Clinical and Translational Hepatology,2017,5(4):319-326. 被引量:3
  • 2[1]Global burden of disease (GBD) for hepatitis C.J Clin Pharmacol 2004; 44:20-29
  • 3[2]Shepard CW,Finelli L,Fiore AE,Bell BP.Epidemiology of hepatitis B and hepatitis B virus infection in United States children.Pediatr Infect Dis J 2005; 24:755-760
  • 4[3]Frank C,Mohamed MK,Strickland GT,Lavanchy D,Arthur RR,Magder LS,El Khoby T,Abdel-Wahab Y,Aly Ohn ES,Anwar W,Sallam I.The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt.Lancet 2000; 355:887-891
  • 5[4]Perz JF,Armstrong GL,Farrington LA,Hutin YJ,Bell BP.The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.J Hepatol 2006; 45:529-538
  • 6[5]Alter MJ,Hutin YJ,Armstrong GL.Epidemiology of hepatitis C.In:Liang TJ,Hoofnagle JH,editors.Hepatitis C.San Diego:Academic Press,2000:169-183
  • 7[6]Alter MJ,Kruszon-Moran D,Nainan OV,McQuillan GM,Gao F,Moyer LA,Kaslow RA,Margolis HS.The prevalence of hepatitis C virus infection in the United States,1988 through 1994.N Engl J Med 1999; 341:556-562
  • 8[7]Armstrong GL,Wasley A,Simard EP,McQuillan GM,Kuhnert WL,Alter MJ.The prevalence of hepatitis C virus infection in the United States,1999 through 2002.Ann Intern Med 2006; 144:705-714
  • 9[8]Law MG,Dore GJ,Bath N,Thompson S,Crofts N,Dolan K,Giles W,Gow P,Kaldor J,Loveday S,Powell E,Spencer J,Wodak A.Modelling hepatitis C virus incidence,prevalence and long-term sequelae in Australia,2001.Int J Epidemiol 2003;32:717-724
  • 10[9]Alter MJ.Prevention of spread of hepatitis C.Hepatology 2002;36:S93-S98

共引文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部